Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced a significant coverage expansion for its NeuroStar transcranial magnetic stimulation (TMS) therapy, as TriWest — the regional administrator for TRICARE — updated …
TRICARE Expands TMS Coverage for Teens as Neuronetics Gains Major Policy Win Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported third-quarter results that highlight accelerating commercial traction for its lead product, YCANTH®, alongside major regulatory and clinical milestones that broaden …
Verrica Posts Strong Q3 as YCANTH Momentum Builds and Late-Stage Pipeline Advances Read More
WAYNE, PA — BTCS Inc. (Nasdaq: BTCS) reported the strongest quarter in its history, delivering explosive revenue growth and transformative gains tied to its Ethereum-first strategy. The company’s third-quarter results …
BTCS Rockets to Record Revenue as Ethereum Strategy Powers a Breakout Quarter Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported continued revenue growth and operational progress in the third quarter of 2025, supported by a strengthened leadership team, expanded sales infrastructure, …
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) reported third-quarter results and detailed an intensifying slate of clinical milestones as its QTORIN platform advances across four rare dermatologic diseases — …
Palvella Races Toward Key 2026 Readouts as Rare-Disease Pipeline Expands Rapidly Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) unveiled compelling new data from its Phase 2 study of VP-315, a first-in-class oncolytic peptide immunotherapy, showing strong local immune activation …
New Cancer Data Hints at a Surgery-Free Future — Verrica’s VP-315 Shows Big Promise Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) delivered another quarter of steady growth and widening profitability, reporting strong third-quarter 2025 results that reflect durable demand for its infrastructure engineering …
Bentley’s Big AI Bet: What’s Fueling the Software Maker’s Surging Momentum? Read More
WEST CHESTER, PA — QVC Group, Inc. (Nasdaq: QVCGA, QVCGP; OTCQB: QVCGB) reported a sharp decline in profitability for the third quarter of 2025, as the company continues to navigate …
QVC Group Reports Steep Earnings Decline as Revenue and Margins Tighten Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) reported third-quarter 2025 financial results and outlined continued progress across its expanding immuno-inflammatory pipeline, emphasizing execution in both oral kinase inhibitors and …
Aclaris Therapeutics Advances Immuno-Inflammatory Pipeline, Targets Four Clinical Programs in 2026 Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) reported third-quarter 2025 financial results and provided an update on its advancing portfolio of late-stage gene therapies for inherited retinal diseases. The biotechnology …
Ocugen Advances Gene Therapy Pipeline as Phase 3 Trials Near Key Milestones Read More